Beijing Huafang Investment

Neurodome is a manufacturer specializing in non-invasive deep brain nerve modulation technology. The company is dedicated to the research and development of innovative products that enhance neurosurgical procedures. Its offerings include wearable medical instruments, medical imaging technology, and medical information systems, all designed to improve patient outcomes and reduce the risks associated with neurosurgery. By focusing on minimally invasive solutions, Neurodome aims to advance the field of neurosurgery through its cutting-edge technology.

Bochuang Biotechnology is a developer of advanced medical repair products focused on the electrochemical assembly of biomacromolecules. The company specializes in creating high-end biological tissue functional membranes and medical devices aimed at addressing the repair needs of alveolar bone, membranes, and diseased corneas in China. Its innovative product line includes artificial corneas, periosteum, dura mater, and nerve sheath, all developed using a unique technology platform for biological macromolecule electrochemical deposition. By leveraging this cutting-edge technology, Bochuang Biotechnology offers restorative therapies for patients suffering from eye diseases and other medical conditions.

Haimai Medical is a platform for tissue engineering and regenerative medicine technology. It focused on the development and manufacture of allogeneic small-caliber tissue-engineered blood vessels suitable for the establishment of chronic renal failure dialysis vascular access, lower extremity arterial trauma blood vessel replacement, lower extremity atherosclerosis, and coronary heart disease bypass surgery.

Zenosic focuses in the design and R&D of high-performance network chips, along with offering leading chip products for cloud service providers, equipment makers, operators, and diverse industries.

Veritas Medicine is a pharmaceutical company that specializes in the development of innovative traditional medicine and CRO services.

Inkodi Electronics is a manufacturer of electronic components that specializes in integrated circuit design, chip R&D and design, analog circuit layout design, and electronic component retail.

Wiseetec is a company that specializes in semiconductor equipment research and development, manufacturing, and sales. The company has specialized in bonding and debonding equipment research and development. The product application encompasses the entire semiconductor field. It provides overall temporary bonding and permanent bonding solutions.

Rongcan Bio is a company focused on the development and industrialization of nucleic acid drugs, specifically mRNA-based pharmaceuticals. It offers a comprehensive range of services that encompass the entire nucleic acid industry chain, including nucleic acid sequence design, synthesis of mRNA raw materials, and the creation of delivery systems. By integrating these processes, Rongcan Bio aims to provide efficient drug delivery solutions for patients and establish itself as a leader in the nucleic acid therapeutics market.

Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.

Xinsu Technology develops, designs, and sells industrial machine vision sensor devices. It is specialized in new energy battery and automobile manufacturing industries. It engaged in intellectual property rights of decoding and reading algorithms and has launched a series of industrial high-performance fixed code readers such as R275-A.

Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.

Tangshi Technology is a platform for research and development for carbon-based materials. It helps in creation, and use of conductive agents and negative electrode materials.

Chuangjian Medical is a technological innovation company that focuses on the creation, sale, and research & development of novel protein- and nucleic acid-based medicines.

Converd is a biotechnology company specializing in the development of oncolytic viruses and cancer immunotherapies. The company harnesses advanced research and development platforms to create innovative treatments aimed at combating various types of cancer. With a team of experts experienced in the entire drug development process, Converd focuses on integrating oncolytic virotherapies with other immunotherapeutic approaches to enhance treatment efficacy. Additionally, the company operates a research center equipped with a functional cytology laboratory and an experimental animal room, facilitating the development of immune cell therapies and immune checkpoint antibodies. Through these efforts, Converd seeks to advance the field of cancer treatment and improve patient outcomes.

Fineimmu specializes in the development of innovative cell therapy drugs and immunodiagnostic products aimed at improving cancer treatment. The company's technology is centered on individualized tumor immunotherapy and immunodiagnostics, enabling healthcare professionals to assess the anti-tumor immune function of key proteins like PD-1 and PD-L1. Fineimmu's approach also includes precise combination therapies and rapid efficacy assessments, which together contribute to effective treatment systems for patients with common malignant tumors. The company aims to enhance therapeutic outcomes through personalized medicine, addressing the unique needs of each patient.

Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.

Haimai Medical is a platform for tissue engineering and regenerative medicine technology. It focused on the development and manufacture of allogeneic small-caliber tissue-engineered blood vessels suitable for the establishment of chronic renal failure dialysis vascular access, lower extremity arterial trauma blood vessel replacement, lower extremity atherosclerosis, and coronary heart disease bypass surgery.